pharmaceutical

DEEP DIVE: Opioids ~ Unsupervised Methods for Kick-back Detection

March 18, 2018March 28, 2018 by Nikolay Rodionov

Alternative Title: How to kill 6 days during Spring Break. The unmasking of the opioids epidemic over the last several years has brought new scrutiny to marketing practices associated with high-risk pharmaceuticals products; Exposé journalistic efforts have been especially effective in shedding light on how misinformation and miscalculations of associated risk factors catalysed a torrent … Continue reading DEEP DIVE: Opioids ~ Unsupervised Methods for Kick-back Detection

rbindlist() for all of you list-of-dataframe monsters

November 2, 2017December 25, 2017 by Nikolay Rodionov

ALAS! Why is gov’t data so terribly structured?! I’ve been working with the CMS Open Payments data recently because the annual datasets offer enough granular info to allow for good modeling practices and pharmaceutical marketing practices are pretty interesting from a policy stand-point. My only harp with the data is it’s poor data structure and … Continue reading rbindlist() for all of you list-of-dataframe monsters